Facility, planned in Twinsburg, Ohio, will be Hitachi's only R&D facility outside Japan.
Tokyo-based Hitachi Healthcare announced plans this week to create a new research-and-development center at its North American headquarters in Twinsburg, Ohio, later this year, focusing on leveraging artificial intelligence to produce the next generation of imaging technology.
According to a company statement, this facility – the Hitachi Healthcare Innovation Center of Excellence – will establish 40 new jobs in sciences and engineering, setting the stage for closer collaboration with key opinions leaders in the industry. When it opens, it will be the company’s only healthcare research-and-development facility outside Japan.
Currently, Hitachi sells and supports medical imaging devices, including CT, MRI, and ultrasound. In December, the company announced its plans to sell its healthcare division to Fujifilm for $1.6 billion, but, based on the
announcement, that move will not affect activities in Northeast Ohio.
Hitachi’s move to further invest in Northeast Ohio was encouraged by BioEnterprise, a nonprofit organization dedicated to growing Cleveland’s healthcare industry, JobsOhio, and Team NEO. Together, those three groups have injected $55 million into new capital expenditures in Northeast Ohio in the past 18 months. In this latest move, JobsOhio awarded Hitachi Healthcare a Research & Development Grant, and company officials said those funds will be applied to prototyping new equipment, software platforms, and facility upgrades to the Twinsburg facility.
“This R&D investment further demonstrates Hitachi Healthcare’s commitment to design and build the next generation of medical devices, software, and solutions to improve the quality of care in Northeast Ohio,” said J.P. Nauseef, JobsOhio president and chief investment officer, in the press statement.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.